SRPT vs TPC · rev $1.90B vs P/E 53, rev $4.33B
Sarepta Therapeutics Inc (SRPT) versus Tutor Perini Corporation (TPC) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Tutor Perini Corporation (TPC) is a engineering & construction company listed on NYSE.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported TPC revenue for 2024-12-31 was $4.33B. Net income was -$122.3M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. TPC currently screens at market cap $4.11B and trailing P/E 53.3.
SRPT currently screens at market cap $2.34B. TPC currently screens at market cap $4.11B and trailing P/E 53.3.
Not investment advice. Open the SRPT and TPC stock pages for the full models.
Not investment advice.